Early research suggests that CBD, a substance naturally found in marijuana, is an effective treatment for minimizing the inflammation experienced by asthma sufferers.
The research study found that the studied rats treated with CBD experienced a reduction in two types of cytokines, known as Tp and Th2. In addition to showing that CBD treatment was effective in reducing cytokine levels, the study also suggests that CBD may influence a reduction in the major stimuli of mucus hyper-secretion, another prominent symptom experienced by those with asthma.
The study’s findings were consistent with that of the Ribero study, which shows CBD to have potent immunosuppressive and anti-inflammatory properties. It is noted, however, that the asthma-associated inflammation of the rat models differed somewhat from that of the LPS-induced inflammation of the mice models being studied for decreasing inflammation due to lung injuries.
This study and many others like it are demonstrating the need for more effective, rigorous and timely studies on the potential medicinal benefits from marijuana.